David Watson - Jun 22, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
General Counsel
Signature
/s/ David Watson
Stock symbol
APLS
Transactions as of
Jun 22, 2022
Transactions value $
-$445,140
Form type
4
Date filed
6/23/2022, 04:22 PM
Previous filing
Apr 27, 2022
Next filing
Jan 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$445K -10K -7.96% $44.51 116K Jun 22, 2022 Direct F1
holding APLS Common Stock 3.33K Jun 22, 2022 Indirect Owner (Custodial Account for Son) F2
holding APLS Common Stock 6.67K Jun 22, 2022 Indirect Owner (The Watson Education Trust) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold in multiple transactions at prices ranging from $44.50 to $44.635, inclusive. The reporting person undertakes to provide to Apellis Pharmaceuticals, Inc., any security holder of Apellis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F2 This represents a custodial account held by the reporting person for the sole benefit of his minor son.
F3 The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.